Keyphrases
Nonhuman Primate
100%
Adenovirus Vaccine
100%
Long-term Protection
100%
Recombinant Adenovirus
100%
Ebola Glycoprotein
100%
Ebola Infection
100%
Primates
57%
Immunization
42%
Specific Antibodies
28%
Diverse Populations
28%
CD8+ T Cells
28%
Sublingual Route
28%
Infectious Virus Particle
28%
United States
14%
Immune Response
14%
Adenovirus
14%
Cell Response
14%
CD4+ T
14%
Rodents
14%
Long-term Efficacy
14%
CD4+ T Cells
14%
Intramuscular Injection
14%
CD4+
14%
West Africa
14%
Global Health
14%
Ebola
14%
CD8+
14%
Ebola Vaccine
14%
Ebola Outbreak
14%
Polyfunctional
14%
Sublingual
14%
Sublingual Immunization
14%
Respiratory Doses
14%
Immunology and Microbiology
Glycoprotein
100%
Adenoviridae
100%
Infection
100%
T-Helper Cell
42%
Cytotoxic T-Cell
42%
Virus Infectivity
28%
Virus Particle
28%
Antibody Response
14%
Immune Response
14%
Ebola Vaccine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Glycoprotein
100%
Adenoviridae
100%
CD8 Antigen
42%
Virus Infectivity
28%
Sublingual Route
28%
Ebola Vaccine
14%
Intramuscular Injection
14%